EGFR and non-small cell lung carcinoma: Activating somatic deletions in exon 19 (del19) and the single amino acid substitution L858R in exon 21 are the “classical” EGFR mutations, accounting for more than 85% of all EGFR mutations in NSCLC patients [1].